Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06259799 · ClinicalTrials.gov registry record · NA

Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students

A NA study of Dehydration, sponsored by Kennesaw State University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06259799: Recruiting NA study of Dehydration, sponsored by Kennesaw State University.

NCT06259799 is a NA study of Dehydration that is actively recruiting participants, run by Kennesaw State University. The registered enrollment target is 30 participants, below the 56-participant average among 20 other Dehydration trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06259799, a NA study of Dehydration, is actively recruiting participants, sponsored by Kennesaw State University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

Approximately 60% of males and 40% of females do not meet current fluid intake recommendations, which is associated with adverse health consequences such as obesity, diabetes, and chronic kidney disease. Newer technologies have been designed to promote fluid intake. "Smart Water Bottles" use mHealth technology to capture fluid intake behaviors automatically and provide cues to encourage fluid consumption. Studies using Smart Water Bottles have helped some individuals increase fluid intake to help reduce kidney stone formation. However, limited research has assessed the efficacy of this technology on improving fluid intake in college students. College is a time with the potential to form healthy habits that carry into adulthood. Previous work has also identified daily changes in morning urine color, thirst perception, and body mass, as simple, inexpensive indicators of daily fluctuations in water balance. Tracking changes in these metrics has the potential to provide participants with evidence of adequate or inadequate fluid consumption. Thus, the combination of prompting from a smart water bottle, as well as daily self-monitoring changes in hydration status, may encourage college students to increase daily fluid consumption.

Primary Outcome

Total Fluid Intake will be reported by participants for 3 days before and after the intervention using a validated fluid log. The average of 3-days of fluid recording will be used.

Conditions Studied

Interventions

  • BEHAVIORAL Smart Water Bottle

Study Locations (1)

Georgia

  • Kennesaw State University - Kennesaw

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-04-01
Est. Completion 2026-04
Phase NA
Kennesaw State University

8 total trials

What NCT06259799 shows while recruiting

NCT06259799 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 56-participant average among 20 other Dehydration trials with a reported enrollment target (46% lower).

The record links to 1 condition, with Dehydration appearing as the primary indexed condition, and to 1 intervention - of which Smart Water Bottle is the first listed.

NCT06259799 reports a single indexed study location in Georgia.

Frequently Asked Questions

What is clinical trial NCT06259799 about?

NCT06259799 is a clinical study titled "Efficacy of a Smart Water Bottle Intervention to Increase Fluid Consumption in College Students". Approximately 60% of males and 40% of females do not meet current fluid intake recommendations, which is associated with adverse health consequences such as obesity, diabetes, and chronic kidney disease. Newer technologies have been designed to promote fluid intake. "Smart Water Bottles" use mHealth...

What is the current status of trial NCT06259799?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-04-01. Estimated completion is 2026-04.

What conditions does trial NCT06259799 study?

This clinical trial studies the following conditions: Dehydration.

What interventions are being tested in trial NCT06259799?

The interventions under investigation include: Smart Water Bottle (BEHAVIORAL).

Who is sponsoring clinical trial NCT06259799?

This trial is sponsored by Kennesaw State University, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06259799 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dehydration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06259799's enrollment target sits among peer trials

30 12th of 20 higher than 9 of 20 other Dehydration trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dehydration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06259799, the US trial registry maintained by the National Library of Medicine. NCT06259799 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.